• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养的10号线肿瘤细胞分泌的隐蔽型和活性纤溶酶原激活剂。

Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture.

作者信息

Orenstein N S, Buczynski A, Dvorak H F

出版信息

Cancer Res. 1983 Apr;43(4):1783-9.

PMID:6682008
Abstract

Line 10 guinea pig carcinoma cells cultured in serum-free medium for 4 hr elaborate plasminogen activator (PA) activity that remained in the supernatant after ultracentrifugation (100,000 X g, 90 min). PA activity in line 10 conditioned medium occurred in both active and cryptic forms. The vast majority of active PA adsorbed to lysine-Sepharose and could be eluted at low pH as several activities that electrophoresed in the Mr 50,000 to 80,000 range on nonreduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A small amount of active PA, running in the Mr 50,000 to 60,000 region, and cryptic PA did not adhere to lysine-Sepharose. Treatment of lysine-Sepharose-nonadherent fractions with catalytic amounts of plasmin or trypsin induced substantial new PA activity that adsorbed to lysine-Sepharose, bound [3H]diisopropylfluorophosphate, and that electrophoresed as several bands of activity with molecular weights from 50,000 to greater than 100,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Of additional interest, the amount of active PA measured in conditioned medium was substantially increased when certain protease inhibitors, tranexamic acid, epsilon-aminocaproic acid, or Trasylol, were included during culture.

摘要

在无血清培养基中培养4小时的10号线豚鼠癌细胞可产生纤溶酶原激活物(PA)活性,该活性在超速离心(100,000×g,90分钟)后仍保留在上清液中。10号线条件培养基中的PA活性以活性形式和潜在形式存在。绝大多数活性PA吸附到赖氨酸-琼脂糖上,并可在低pH下洗脱,表现为几种在非还原十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上迁移率在Mr 50,000至80,000范围内的活性。少量在Mr 50,000至60,000区域迁移的活性PA和潜在PA不粘附于赖氨酸-琼脂糖。用催化量的纤溶酶或胰蛋白酶处理赖氨酸-琼脂糖非粘附部分可诱导大量新的PA活性,该活性吸附到赖氨酸-琼脂糖上,结合[3H]二异丙基氟磷酸,并在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上表现为几条活性带,分子量从50,000到大于100,000。另外有趣的是,当在培养过程中加入某些蛋白酶抑制剂,如氨甲环酸、ε-氨基己酸或抑肽酶时,条件培养基中测得的活性PA量会显著增加。

相似文献

1
Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture.培养的10号线肿瘤细胞分泌的隐蔽型和活性纤溶酶原激活剂。
Cancer Res. 1983 Apr;43(4):1783-9.
2
Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.血管平滑肌细胞抑制内皮细胞分泌的纤溶酶原激活剂。
Thromb Haemost. 1985 Apr 22;53(2):165-9.
3
Characterization of plasminogen activator from two human renal carcinoma cell lines.两种人肾癌细胞系纤溶酶原激活物的特性分析
J Cell Physiol. 1986 Mar;126(3):435-43. doi: 10.1002/jcp.1041260315.
4
Secretion of plasminogen activators by cultured bovine endothelial cells: partial purification, characterization and evidence for multiple forms.培养的牛内皮细胞纤溶酶原激活剂的分泌:部分纯化、特性鉴定及多种形式的证据
Thromb Haemost. 1981 Jun 30;45(3):219-24.
5
Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.视黄酸调节DU-145人前列腺癌细胞中细胞外尿激酶型纤溶酶原激活剂的活性。
Clin Cancer Res. 1995 Jul;1(7):747-53.
6
Characterization of plasminogen activator produced by an established cell line from human ovary.源自人卵巢的一个成熟细胞系所产生的纤溶酶原激活物的特性分析。
J Cell Physiol. 1988 Feb;134(2):253-60. doi: 10.1002/jcp.1041340211.
7
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Thromb Haemost. 1981 Oct;46(3):642-4.
8
Plasminogen activator: the major secreted neutral protease of cultured skeletal muscle cells.纤溶酶原激活剂:培养的骨骼肌细胞分泌的主要中性蛋白酶。
J Cell Physiol. 1982 Feb;110(2):190-5. doi: 10.1002/jcp.1041100213.
9
Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.去势对大鼠前列腺腹叶纤溶酶原激活物活性及1型纤溶酶原激活物抑制剂的影响。
Prostate. 1996 Apr;28(4):239-50. doi: 10.1002/(SICI)1097-0045(199604)28:4<239::AID-PROS5>3.0.CO;2-8.
10
A comparison of plasminogen activators derived from rat plasma, primary rat hepatocytes and isolated perfused rat liver.源自大鼠血浆、原代大鼠肝细胞和离体灌注大鼠肝脏的纤溶酶原激活剂的比较。
Thromb Haemost. 1982 Apr 30;47(2):166-72.

引用本文的文献

1
Breast cancer prognosis is poor when total plasminogen activator activity is low.当总纤溶酶原激活剂活性较低时,乳腺癌的预后较差。
Br J Cancer. 1993 Feb;67(2):374-8. doi: 10.1038/bjc.1993.68.
2
Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer.组织型和尿激酶型纤溶酶原激活剂在人类乳腺癌中的生物学差异意义
Br J Cancer. 1993 Sep;68(3):524-9. doi: 10.1038/bjc.1993.380.
3
Importance of viability and attachment to an ascites tumor in the release of plasminogen activator.纤溶酶原激活物释放中腹水肿瘤的活性及附着的重要性。
Am J Pathol. 1991 May;138(5):1103-10.